PHARMACYTE BIOTECH, INC. Deferred Tax Assets, Operating Loss Carryforwards
PHARMACYTE BIOTECH, INC. (PMCB) had Deferred Tax Assets, Operating Loss Carryforwards of $16.08 million as of 2026-04-30, per its 10-K filed 2026-07-29.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-07-29
- 2026-04-30: Deferred Tax Assets, Operating Loss Carryforwards $16.08M.
- 2025-04-30: Deferred Tax Assets, Operating Loss Carryforwards $15.03M.
- 2024-04-30: Deferred Tax Assets, Operating Loss Carryforwards $14.44M.
- 2023-04-30: Deferred Tax Assets, Operating Loss Carryforwards $15.73M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2026-04-30 | $16.08M 10-K · filed 2026-07-29 | |
| 2025-04-30 | $15.03M 10-K · filed 2026-07-29 | |
| 2024-04-30 | $14.44M 10-K · filed 2025-08-11 | |
| 2023-04-30 | $15.73M 10-K · filed 2024-08-13 | |
| 2022-04-30 | $15.14M 10-K · filed 2023-07-31 | |
| 2021-04-30 | $13.80M 10-K · filed 2022-07-28 | |
| 2020-04-30 | $12.90M 10-K · filed 2021-08-10 | |
| 2019-04-30 | $11.85M 10-K · filed 2020-08-13 | |
| 2018-04-30 | $11.04M 10-K · filed 2019-08-13 | |
| 2017-04-30 | $13.68M 10-K · filed 2018-07-20 | |
| 2016-04-30 | $14.27M 10-K · filed 2017-07-27 | |
| 2015-04-30 | $13.12M 10-K · filed 2016-07-29 | |
| 2014-04-30 | $21.33M 10-K/A · filed 2016-01-19 | -$36.64M 10-K · filed 2014-08-04 |
| 2013-04-30 | -$35.37M 10-K · filed 2014-08-04 | $36.64M 10-K · filed 2013-07-29 |
| 2012-04-30 | $35.88M 10-K · filed 2013-07-29 | |
| 2011-04-30 | $35.37M 10-K · filed 2013-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |